Both Victoza and Ozempic can help reduce the risk of heart attack and stroke in people with type 2 diabetes. Victoza is ...

It has been announced that Victoza® (generic name: liraglutide), a GLP-1 receptor agonist that has long been used in diabetes ...

SAN DIEGO, June 25, 2011 /PRNewswire/ -- Novo Nordisk will present data from two extension studies at the 71st Annual Scientific Sessions of the American Diabetes Association (ADA) which show that ...

Hello! In this article, I will explain in an easy-to-understand way the differences between "Victoza"and"Mounjaro," which are ...

Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes and reduce certain heart risks. Its mechanism of action is mimicking a natural hormone (GLP-1) that manages your blood sugar ...

SAN DIEGO, April 14, 2011 /PRNewswire/ -- Novo Nordisk presented data today that showed regardless of baseline A1C, once-daily Victoza® (liraglutide [rDNA origin] injection) 1.8 mg consistently helped ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Liraglutide was not ...

Novo Nordisk inked a new patent settlement aiming to protect Victoza exclusivity for a few more years. (Artist rendering/Novo Nordisk) Novo Nordisk has at least four more years to build up its newer ...

Victoza (once-daily), along with proper diet and physical activity, showed greater weight loss at 56 weeks compared with placebo, in type II diabetic patients who are overweight or suffering from ...

Novo Nordisk NVO announced positive top-line results on its diabetes drug, Victoza, from the LEADER trial. This multicenter, double-blind, placebo-controlled trial evaluated the cardiovascular safety ...

Novo says the manufacturing of Victoza and its other liraglutide containing drugs is so complex that generics should go through clinical trials to prove equivalence. With one drugmaker already trying ...